| mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
0.0033 |
0.9 |
| mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0032 |
0.9 |